Promethazine for peak identification

Hazard statements (CLP)

H302, H317, H318, H411

Code

Statements

H302

Harmful if swallowed

SECTION 2: Hazards identification

Adverse physicochemical, human health and environmental effects

Expert judgement and weight of evidence determination.

2.2 Label elements

Labelling

Hazard pictograms

GHS05 GHS07 GHS09 GHS05

Signal word

Danger

Contains

Promethazine hydrochloride; Phenothiazine ; 10H-Phenothiazine-10-ethanamine, N,alpha- dimethyl-, monohydrochloride

Hazard statements

H302 - Harmful if swallowed. H317 - May cause an allergic skin reaction. H318 - Causes serious eye damage. H411 - Toxic to aquatic life with long lasting effects.

Precautionary statements

P261 - Avoid breathing dust/fume/gas/mist/vapours/spray. P264 - Wash hands, forearms and face thoroughly after handling. P270 - Do not eat, drink or smoke when using this product. P272 - Contaminated work clothing should not be allowed out of the workplace. P273 - Avoid release to the environment. P280 - Wear protective gloves/protective clothing/eye protection/face protection/hearing protection. P301+P312 - IF SWALLOWED: Call a POISON CENTRE or doctor if you feel unwell. P302+P352 - IF ON SKIN: Wash with plenty of water. P305+P351+P338 - IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P310 - Immediately call a POISON CENTER or doctor. P321 - Specific treatment (see supplemental first aid instruction on this label). P330 - Rinse mouth. P333+P313 - If skin irritation or rash occurs: Get medical advice/attention. P362+P364 - Take off contaminated clothing and wash it before reuse. P391 - Collect spillage. P501 - Dispose of contents/container to hazardous or special waste collection point, in accordance with local, regional, national and/or international regulation. Labelling according to: exemption for inner packaging where the contents do not exceed 10ml

Hazardous Ingredients

Promethazine hydrochloride; Phenothiazine ; 10H-Phenothiazine-10-ethanamine, N,alpha- dimethyl-, monohydrochloride

2.3 Other hazards

Contains no PBT and/or vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 %